Effects of IL‐32 polymorphisms and IL‐32 levels on the susceptibility and severity of coronary artery disease

BACKGROUND: Interleukin‐32 (IL‐32) has long been proposed as a biomarker for coronary artery disease (CAD). We aimed to evaluate the association between IL‐32 levels and coronary stenosis severity, IL‐32 polymorphisms rs28372698 and rs4786370, and CAD susceptibility. METHODS: A total of 362 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Susu, Liu, Xiujing, Wang, Yingying, Yu, Jian, Jiang, Minghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761453/
https://www.ncbi.nlm.nih.gov/pubmed/34799941
http://dx.doi.org/10.1002/jcla.24114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761453/
https://www.ncbi.nlm.nih.gov/pubmed/34799941
http://dx.doi.org/10.1002/jcla.24114

Ejemplares similares